Clin2
NCT06382844Likely a fitRecruiting

Better detection of tumor cells in cutaneous T-cell lymphoma

Cutaneous T-Cell Lymphoma

Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.

This study uses advanced blood tests (flow cytometry) to find cancer cells more accurately in people with cutaneous T-cell lymphoma. It could lead to better monitoring of your condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with cutaneous T-cell lymphoma
  • You are 18 years old or older
  • You are willing to sign a consent form agreeing to take part

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06651203Not yet recruiting
Blood test for KIR3DL2 in Sézary syndrome diagnosis and monitoring

This study tests a new blood test that looks for a marker called KIR3DL2 on cancer cells to help diagnose Sézary syndrome, a rare type of skin lymphoma. It may also help doctors see how well treatment is working and if any cancer cells remain after treatment.

NCT00177268Recruiting
Collecting blood and tissue samples in skin diseases research

This study collects blood, urine, and possibly small tissue samples to learn more about cutaneous T-cell lymphoma (CTCL) and either eczema or atopic dermatitis. It may help researchers better understand these skin conditions and improve future treatments.

Pittsburgh, Pennsylvania
NCT06436677Recruiting
New treatment plans based on CTCL genetic type

This trial is testing new treatment plans based on the genetic type of your cutaneous T-cell lymphoma (CTCL). It's for people whose CTCL did not respond well to standard skin treatments.

Beijing, Beijing Municipality
NCT06588868Recruiting
Systemic treatments for cutaneous T-cell lymphoma

This trial looks at the results of different systemic (whole-body) treatments for cutaneous T-cell lymphoma (CTCL), a rare type of lymphoma that affects the skin. It aims to understand how well these therapies work and help guide future treatment choices.

Ancona
NCT04045470Recruiting
Skin-device test to find drugs for T-cell lymphoma lesions

This trial tests a tiny device placed directly into skin lymphoma spots to help identify which “candidate” drugs could work. It’s mainly aimed at people with measurable skin involvement from T-cell lymphoma, after they stop certain treatments for a set time.

Boston, Massachusetts
NCT07658924Not yet recruiting· Phase 2
Testing benvitimod cream for skin lymphoma

This study tests a cream called benvitimod to see if it helps treat cutaneous T-cell lymphoma, a type of skin lymphoma. It is for adults who have already been diagnosed with this condition.

Hear when a new Cutaneous T Cell Lymphoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.